Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial

NCT01761461 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01761461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01761461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
February 6, 2013
Completion date
December 31, 2020
Enrollment
547 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer